Venkatesan Jay
CIK 0001413350
See RemarksDirector10% Owner
Filings
15
Latest Apr 21, 2026
Issuers covered
3
Showing
15 of 15
Page 1
Track record
4 of 4 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 4 | 75% | +30.9% | +37.9% | +60.2% | -12.3% |
| 90 days | 4 | 25% | -8.3% | -18.9% | +24.9% | -20.3% |
| 180 days | 4 | 25% | -13.8% | -31.5% | +40.4% | -32.5% |
| 365 days | 4 | 25% | -4.6% | -32.9% | +87.2% | -39.8% |
Issuers
Companies where Venkatesan Jay has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ELTX | Elicio Therapeutics, Inc. | 10 | May 20, 2025 |
| AGE | Agex Therapeutics, Inc. | 4 | Apr 21, 2026 |
| ALPN | Alpine Immune Sciences, Inc. | 1 | Jan 4, 2022 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|